14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
ACB vs MTLS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Materialise NV (MTLS) is the stronger overall head-to-head candidate over Aurora Cannabis Inc. Common Shares (ACB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACB carries a Unified Composite Score of 40.1/100 (SELL) at $4.52 (109.9x Forward P/E, -13.8% operating margin), whereas MTLS carries 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACB vs MTLS. Trailing 12-month operating profitability (ACB -13.8% vs MTLS 3.4%) and valuation multiples (ACB 109.9x vs MTLS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Software - Application value chain with $369.9M market capitalization and 3.4% operating margin.
OpEx & R&D Reinvestment54.0% of Rev ($327M)
90D Engineering Disclosures0 Published
Investor FAQ ACB vs MTLS Key Questions & Quantitative Answers
As of Nov 17, 2026, Materialise NV (MTLS) is the stronger overall head-to-head candidate over Aurora Cannabis Inc. Common Shares (ACB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACB carries a Unified Composite Score of 40.1/100 (SELL) at $4.52 (109.9x Forward P/E, -13.8% operating margin), whereas MTLS carries 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin). Technically, ACB sits in a Neutral phase (RSI 49.2, CONSOLIDATION options structure) and MTLS sits in a Neutral phase (RSI 31.4, UNCLASSIFIED options structure).
MTLS leads the Growth & Scale pillar: ACB posts -8.8% YoY revenue growth and -94.7% YoY earnings growth on $314M TTM revenue (44.2% gross margin, -13.8% operating margin), compared with MTLS at +2.1% YoY revenue growth and -33.3% YoY earnings growth on $605M TTM revenue (57.4% gross margin, 3.4% operating margin). On trailing 12-month operating scale, ACB generates $314M in USD-normalized revenue versus $605M for MTLS. In operating R&D and SG&A reinvestment, ACB deploys 58.0% of Rev ($182M) (0 90-day corporate R&D disclosures) versus 54.0% of Rev ($327M) (0 disclosures) for MTLS.
MTLS screens cheaper on headline valuation multiples. ACB trades at 109.9x Forward P/E, 109.9x Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-8.1% FCF margin), whereas MTLS trades at N/M Forward P/E, 25.0x Trailing P/E, 1.26x PEG, and 0.6x EV/Revenue (9.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACB (-9.4% ROE) versus MTLS (5.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ACB carries 30.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.23x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.08β · 86% Vol realized risk). By comparison, MTLS carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 88% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.